1. Home
  2. GRML vs ATCH Comparison

GRML vs ATCH Comparison

Compare GRML & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenland Mines Ltd. Common Stock

GRML

Greenland Mines Ltd. Common Stock

N/A

Current Price

$0.23

Market Cap

34.9M

Sector

N/A

ML Signal

N/A

Logo AtlasClear Holdings Inc.

ATCH

AtlasClear Holdings Inc.

HOLD

Current Price

$0.19

Market Cap

29.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRML
ATCH
Founded
N/A
2022
Country
United States
United States
Employees
5
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
34.9M
29.6M
IPO Year
2022
2024

Fundamental Metrics

Financial Performance
Metric
GRML
ATCH
Price
$0.23
$0.19
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.00
AVG Volume (30 Days)
3.3M
1.4M
Earning Date
05-13-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.05
Revenue
N/A
N/A
Revenue This Year
N/A
$84.47
Revenue Next Year
N/A
$39.32
P/E Ratio
N/A
$3.88
Revenue Growth
N/A
N/A
52 Week Low
$0.21
$0.14
52 Week High
$0.55
$1.92

Technical Indicators

Market Signals
Indicator
GRML
ATCH
Relative Strength Index (RSI) 33.51 41.77
Support Level $0.21 $0.19
Resistance Level $0.34 $0.22
Average True Range (ATR) 0.04 0.01
MACD -0.00 0.00
Stochastic Oscillator 16.57 25.65

Price Performance

Historical Comparison
GRML
ATCH

About GRML Greenland Mines Ltd. Common Stock

Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.

About ATCH AtlasClear Holdings Inc.

AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.

Share on Social Networks: